Clinical Trial Update: Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial is evaluating the combination of blinatumomab and asciminib in adults with Philadelphia chromosome-positive acute lymphoblastic leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Asciminib (asciminib)
• Blinatumomab (blinatumomab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Philadelphia Chromosome-Positive, Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: RECRUITING